Director Kevin D. Deane, MD/PhD
Dr. Deane is a Professor of Medicine in the Division of Rheumatology at the University of Colorado Anschutz Medical Campus. He has been PI or Co-I on multiple observational studies of preclinical rheumatoid arthritis; in addition, he is the PI on the ongoing NIH-funded StopRA trial that is studying the role of hydroxychloroquine to prevent or delay the onset of rheumatoid arthritis in high-risk individuals.
Co-Director Jill M. Norris, MPH/PhD
Dr. Norris is a Professor of Epidemiology and Chair of the Department of Epidemiology at the Colorado School of Public Health. She has been the PI or Co-I on multiple pre-clinical and epidemiological studies across a number of autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, and others.
Statistician Brandie Wagner, PhD
Dr. Wagner is an Associate Professor of Biostatistics in the Department of Biostatistics and Informatics at the Colorado School of Public Health. She has worked extensively in analyses of complex cross-sectional and longitudinal data, including microbiome analyses and biomarker discovery.
Core Manager Marie L. Feser, MSPH
Ms. Feser has extensive experience as project manager of multiple observational and clinical trials in autoimmune diseases.
Data Manager LauraKay Moss, BS
Ms. Moss has extensive experience in data management and delivery of high-quality datasets for analyses.